As the legal cannabis market continues to expand into new jurisdictions across the globe, companies are beginning to take advantage of the new research being conducted on the medical benefits of cannabis and cannabis-based derivatives. While legal issues have previously hindered research concerning cannabis, recent legislative changes have created new opportunities for cannabis-based medicines.

Canadian biotech company Cardiol Therapeutics Inc. (TSX:CRDL) (OTC:CRTPF) is targeting this new market segment by developing cannabidiol-based treatments that can be delivered directly to the site of disease or infection in the body. The company was recently featured in Technical 420, who believe 2019 could be a significant year for Cardiol as the pharmaceutical CBD market continues to develop.


Cardiol Therapeutics is also in development of a pure, pharmaceutical-grade CBD compound. According to Technical 420, Cardiol’s treatment method “represents a significant opportunity for the cannabis biotech company.” The company plans to introduce a high-purity CBD product to the Canadian market in the near future.

Read the full article here.

Click here to connect with Cardiol Therapeutics (TSX:CRDL) for an investor presentation. 

 

 Matica Enterprises Inc. (CSE: MMJ) (OTCQB: MMJFF) (FSE: 39N) (“Matica” or the “Company”) reports the Company has granted 6,500,000 stock options exercisable at $0.05 for five years from date of grant. These include 4,000,000 options to two officers (who are also directors) and, 2,500,000 to two consultants.

For more information on Matica Enterprises please visit the website at: www.maticaenterprises.com.

Keep reading... Show less

The Company welcomes adult-use customers at its eight dispensaries across the state and will create 120 new jobs in surrounding communities

– Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading U.S. provider of consumer products in cannabis, today announced it will begin serving adult-use consumers across its eight dispensaries in Arizona .

Keep reading... Show less

Harvest Health & Recreation Inc. (“Harvest”) (CSE: HARV, OTCQX: HRVSF), a vertically integrated cannabis company and multi-state operator in the U.S., today announced the launch of recreational cannabis sales in Arizona .

Keep reading... Show less

Jason Mitchell Co-Founder, Director and Chief Executive Officer, HempFusion Wellness Inc. (“HempFusion” or the “Company”) (TSX: CBD.U), and his team joined David Chelich Sector Head, Global Energy and Diversified Industries, TMX Group, to celebrate the Company’s new listing on Toronto Stock Exchange and open the market.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it is one of the seventeen companies in the U.S. and Canada that will be included in the First Psychedelics Exchange Traded Fund, which is managed by Horizons ETF Management.

The Horizons Psychedelic Stock Index ETF index is expected to start trading on Tuesday, January 26, under the ticker PSYK on the NEO exchange.

Keep reading... Show less